Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMU6AMP)

• Drug Name: IL-2 antibody (anti-tumor) Drug Info
• Synonyms: DMS-1.10; anti-human rIL-2 antibody, Hybritech

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID: TTD Drug ID: DMU6AMP

Molecule-Related Drug Atlas

Drug(s) Targeting Interleukin-2 (IL2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Aldesleukin	DM4YMIS	Acute myelogenous leukaemia	2A41	Approved	[2]
Daclizumab	DM6OZQV	Aplastic anemia	3A70	Approved	[3]
AIR-insulin	DM8SYTE	Diabetic complication	5A2Y	Phase 3	[4]
TG-4010	DMWE3GB	Bipolar disorder	6A60	Phase 2/3	[5]
BNZ-1	DM8JQZC	Cutaneous T-cell lymphoma	2B01	Phase 2	[6]
IL-2/CD40L-expressing leukemia vaccine	DMIHQ5G	Chronic lymphocytic leukaemia	2A82.0	Phase 2	[7]
Carboxyamidotriazole orotate	DMN5JCX	Glioblastoma multiforme	2A00.0	Phase 2	[8]
Leuvectin	DM5LQEI	Melanoma	2C30	Phase 2	[9]
Human interleukin-2	DM0NJWG	Renal cell carcinoma	2C90	Phase 2	[10]
L19-IL-2 fusion protein	DMI2XP1	Lymphoma	2A80-2A86	Phase 2	[11]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin-2 (IL2)	TTF89GD	IL2_HUMAN	Modulator	[1]

References

• [1] An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2. Immunopharmacology. 1994 Nov-Dec;28(3):223-32.
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [3] 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
• [4] The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data. Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S41-7.
• [5] A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer. J Thorac Oncol. 2008 Jul;3(7):735-44.
• [6] Clinical pipeline report, company report or official report of Bioniz Therapeutics.
• [7] Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and a... Blood. 2006 Feb 15;107(4):1332-41.
• [8] J Clin Oncol 32:5s, 2014 (suppl; abstr 2071).
• [9] Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex. World J Urol. 2000 Apr;18(2):152-6.
• [10] Clinical pipeline report, company report or official report of Immunservice.
• [11] National Cancer Institute Drug Dictionary (drug id 665656).